These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27568664)

  • 1. Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer.
    Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BS; Rakha EA; Nolan C; Ellis IO; Green AR
    Malays J Pathol; 2016 Aug; 38(2):83-92. PubMed ID: 27568664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
    Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
    Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart.
    Agboola AO; Banjo AA; Anunobi CC; Ayoade BA; Deji-Agboola AM; Musa AA; Abdel-Fatah T; Nolan CC; Rakha EA; Ellis IO; Green AR
    Malays J Pathol; 2014 Apr; 36(1):3-17. PubMed ID: 24763230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women.
    Agboola A; Musa A; Banjo A; Ayoade B; Deji-Agboola M; Nolan C; Rakha E; Ellis I; Green A
    J Clin Pathol; 2014 Apr; 67(4):301-6. PubMed ID: 24170211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women.
    Agboola AJ; Musa AA; Wanangwa N; Abdel-Fatah T; Nolan CC; Ayoade BA; Oyebadejo TY; Banjo AA; Deji-Agboola AM; Rakha EA; Green AR; Ellis IO
    Breast Cancer Res Treat; 2012 Sep; 135(2):555-69. PubMed ID: 22842985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications.
    Agboola AO; Ebili HO; Iyawe VO; Banjo AA; Salami BA; Rakha EA; Nolan CC; Ellis IO; Green AR
    Pathol Res Pract; 2017 Jan; 213(1):27-33. PubMed ID: 27914769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women.
    Agboola AO; Banjo AA; Anunobi CC; Salami B; Agboola MD; Musa AA; Nolan CC; Rakha EA; Ellis IO; Green AR
    ISRN Oncol; 2013; 2013():675051. PubMed ID: 23691362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
    Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
    J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
    Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
    Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
    Rodríguez-Pinilla SM; Sarrió D; Honrado E; Moreno-Bueno G; Hardisson D; Calero F; Benítez J; Palacios J
    J Clin Pathol; 2007 Sep; 60(9):1006-12. PubMed ID: 17105822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.
    Niwińska A; Olszewski W; Murawska M; Pogoda K
    J Neurooncol; 2011 Dec; 105(3):547-53. PubMed ID: 21656328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.
    Czapiewski P; Wełnicka-Jaśkiewicz M; Seroczyńska B; Skokowski J; Sejda A; Szade J; Wiewiora C; Biernat W; Żaczek A
    Pol J Pathol; 2015 Sep; 66(3):269-75. PubMed ID: 26619106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
    Baker BG; Ball GR; Rakha EA; Nolan CC; Caldas C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2013 Jan; 137(1):127-37. PubMed ID: 23208589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
    Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
    J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
    Tan DS; Marchió C; Jones RL; Savage K; Smith IE; Dowsett M; Reis-Filho JS
    Breast Cancer Res Treat; 2008 Sep; 111(1):27-44. PubMed ID: 17922188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
    Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
    Asleh K; Won JR; Gao D; Voduc KD; Nielsen TO
    Breast Cancer Res Treat; 2018 Feb; 168(1):107-115. PubMed ID: 29159761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.